LAURA LIPSETT: Open Payments
NPI 1285857672 · HIAWATHA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 25 payments from 13 companies in 2025. Trend: 2023 $385 · 2024 $454 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $122 |
| Biogen, Inc. | 5 | $98 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $76 |
| Octapharma USA, Inc. | 2 | $48 |
| CooperSurgical, Inc. | 2 | $43 |
| Hologic Sales and Service, LLC | 1 | $30 |
| Novo Nordisk Inc | 1 | $25 |
| PFIZER INC. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
Products named: Veozah, ZURZUVAE, FIBRYGA, Paragard T 380A, MYOSURE TISSUE REMOVAL DEVICE, Wegovy, COMIRNATY, GEMTESA.
Industry payments across IA — which companies pay providers there.
